| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | WO2001068072A3 Composition for use in treatment of ocular hypertension and glaucoma |
| 06/06/2002 | WO2001068071A3 Use of natural chrysanthone compounds having antiangiogenic activity |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases |
| 06/06/2002 | US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
| 06/06/2002 | US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc. |
| 06/06/2002 | US20020068729 Quaternary salts of substituted imidazoles, oxazoles and thiazoles |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068102 Use of dietary supplement includes juice from fruit of Morinda citrifolia to scavange lipid hydroperoxides and superoxide anion free radicals within the human body |
| 06/06/2002 | CA2430409A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430309A1 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2429615A1 Determination of risk and treatment of complications of prematurity |
| 06/06/2002 | CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/05/2002 | EP1211242A1 Prostaglandin derivatives |
| 06/05/2002 | EP1210948A1 Remedies for nervous diseases |
| 06/05/2002 | EP1210947A1 Ophthalmic ointments for treating infective eye diseases |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210350A1 Water soluble sdz-rad esters |
| 06/05/2002 | EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210099A1 Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras |
| 06/05/2002 | EP1210094A1 Herbal compositions and uses for the treatment of allergic reactions |
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1039895B1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma |
| 06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | CN1352638A Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 06/05/2002 | CN1352565A Agent for treating visual cell function disorder |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1085945C 7-(2-imidazolinylamino) quinoline compounds as alpha -2 adrenocepter agonists |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
| 06/04/2002 | US6399637 Crystal modification of torasemide |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease |
| 06/04/2002 | US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists |
| 06/04/2002 | US6399605 Ophthalmic composition comprising a beta -blocker |
| 06/04/2002 | US6399601 Antidiabetic agents; nervous system disorders; anticholesterol agents |
| 06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
| 06/04/2002 | US6397849 Methods of ophthalmic administration |
| 06/04/2002 | CA2302396C Allosteric adenosine receptor modulators |
| 06/04/2002 | CA2234367C Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042280A2 Pyrimidine derivatives |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002041917A1 Ophthalmological preparations |
| 05/30/2002 | WO2002041910A2 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | WO2002041909A1 Method and preparations having effect against allergic symptoms |
| 05/30/2002 | WO2002041896A2 Use of thienopyrimidines |
| 05/30/2002 | WO2002041882A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/30/2002 | WO2002041880A2 Use of pyrazolo[4,3-d]pyrimidines |
| 05/30/2002 | WO2002041837A2 Treatment of mucositis |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002013805A3 Method of treating neurodegenerative disorders of the retina and optic nerve head |
| 05/30/2002 | WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 05/30/2002 | WO2001095928A3 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 05/30/2002 | WO2001092274A3 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 05/30/2002 | WO2001087913A3 Method for treating retinal degeneration with purinergic receptor agonists |
| 05/30/2002 | WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 05/30/2002 | WO2001085149A3 Felbamate derived compounds |
| 05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 05/30/2002 | WO2001072714A3 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020065416 Anti-inflammatory agents |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/30/2002 | US20020065299 Administering for therapy of mitochondria medited disease |
| 05/30/2002 | US20020065298 Mitochondria protecting agents for treating mitochondria associated diseases |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065280 Oxazolidinones to treat eye infections |
| 05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
| 05/30/2002 | US20020065269 3-Sulfonylamino-c5 to c8-methyleneimino-2-carboxylic acid compound is effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065256 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064565 Treating an eye infections; cleansing a contact lens in place on an eye |
| 05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
| 05/30/2002 | US20020064525 Anti-IgE vaccines |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | US20020064503 Administering dose of mixture of lipid crystals comprising surfactant and spreading agnet as aerosol through an external airway of a mammal for enhancing mammalian eustachian tube lumen patency and pressure equalization performance |